Taste and Smell Dysfunction in Patients More Than Two Years After Start of Immune Checkpoint Inhibitor Therapy

NCT06495008 · clinicaltrials.gov ↗

COMPLETED

Status

101

Enrollment

OTHER

Sponsor class

Conditions

Melanoma
Non-small Cell Lung Cancer (NSCLC)
Urogenital Cancers

Interventions

OTHER: no intervention, only questionnaires, saliva collection and taste/smell tests

Sponsor

University Medical Center Groningen